Our lab is proud to undertaking novel, cutting-edge research in the field of exosome derived biomarkers of drug exposure. We are passionate about translating pharmacokinetic principles into clinical practice through the optimization of drug dosing with a specific interest in precision dosing of anti-cancer drugs to achieve optimal therapeutic outcomes for oncology patients.